Company research
Future Health ESG Corp.
CIK 1851182Updated Sep 24, 2026
Securities
FHLT price & chart
Historical security
This listing closed Feb 11, 2025. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Financials
FY 2023 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 17,229,180Source | 17,258,387Source | 202,633,352Source |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 119,745Source | 837,692Source | 1,446,482Source |
| Assets, CurrentUSD | 127,245Source | 927,138Source | 1,554,632Source |
| Other Assets, NoncurrentUSD | — | — | 74,371Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 17,440,727Source | 10,315,245Source | 9,123,784Source |
| Stockholders’ equity: | |||
| Common Stock, Value, IssuedUSD | 500Source | 500Source | 500Source |
| Additional Paid in CapitalUSD | — | 0Source | — |
| Retained Earnings (Accumulated Deficit)USD | -10,278,077Source | -9,388,607Source | -7,490,932Source |
| Stockholders' Equity Attributable to ParentUSD | -10,277,577Source | -9,388,107Source | -7,490,432Source |
| Liabilities and EquityUSD | 17,229,180Source | 17,258,387Source | 202,633,352Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 8,440,727Source | 1,315,245Source | 123,784Source |
| Accounts Payable, CurrentUSD | — | — | 20,904Source |
| Additional Financial Items | |||
| Accrued Liabilities, CurrentUSD | — | — | 40,581Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -48,425Source | 59,807Source | -180,911Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -717,947Source | -1,257,384Source | -243,997Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | 187,274,827Source | -201,000,000Source |
| Cash flows from financing activities: | |||
| Payments for Repurchase of Common StockUSD | 7,035,905Source | 186,626,233Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | -186,626,233Source | 202,690,479Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -717,947Source | -608,790Source | 1,446,482Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 119,745Source | 837,692Source | 1,446,482Source |
| Supplemental disclosure of cash flow information: | |||
| Income Taxes Paid, NetUSD | 144,810Source | — | — |
| Additional Financial Items | |||
| Gain (Loss) on InvestmentsUSD | 770,686Source | 2,601,727Source | 4,349Source |
| General and Administrative ExpenseUSD | 627,731Source | 2,206,911Source | 125,004Source |
| Income Tax Expense (Benefit)USD | 153,992Source | 144,810Source | — |
| Investment Income, InterestUSD | 13,472Source | 10,332Source | 2,043Source |
| Net Income (Loss) Attributable to ParentUSD | -48,425Source | 59,807Source | -180,911Source |
| Proceeds from Issuance of Common StockUSD | — | — | 33,333Source |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Operating Income (Loss)USD | -678,591Source | -2,407,442Source | -187,303Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 105,567Source | 204,617Source | — |
| Income Tax Expense (Benefit)USD | 153,992Source | 144,810Source | — |
| Net Income (Loss) Attributable to ParentUSD | -48,425Source | 59,807Source | -180,911Source |
| Additional Financial Items | |||
| Gain (Loss) on InvestmentsUSD | 770,686Source | 2,601,727Source | 4,349Source |
| General and Administrative ExpenseUSD | 627,731Source | 2,206,911Source | 125,004Source |
| Investment Income, InterestUSD | 13,472Source | 10,332Source | 2,043Source |